Get the Stockscreener App
0.00
100.00%
-0.3291
After Hours:
.33
0.33
+
Allakos Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
See More
Previous Close:
$0.3291
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$29.69M
Revenue:
-
Net Income/Loss:
$-166.14M
P/E Ratio:
0.00
EPS:
-1.92
Net Cash Flow:
$-139.92M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.555
Allakos Inc Stock (ALLK) Company Profile
Name
Allakos Inc
Sector
Industry
Phone
650-597-5002
Address
825 INDUSTRIAL ROAD, SAN CARLOS, CA
Compare ALLK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLK
Allakos Inc
|
0.00 | 29.69M | 0 | -166.14M | -139.92M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Allakos Inc Stock (ALLK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-17-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-16-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-18-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-08-23 | Resumed | Jefferies | Buy |
| Sep-27-23 | Initiated | JMP Securities | Mkt Outperform |
| May-12-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-07-23 | Initiated | Piper Sandler | Overweight |
| Sep-12-22 | Downgrade | SMBC Nikko | Neutral → Underperform |
| Dec-22-21 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-22-21 | Downgrade | Cowen | Outperform → Market Perform |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Dec-22-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-22-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-26-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-15-21 | Initiated | Cowen | Outperform |
| May-18-21 | Initiated | H.C. Wainwright | Buy |
| Feb-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | BofA Securities | Buy |
| Dec-21-20 | Initiated | SVB Leerink | Outperform |
| Feb-27-20 | Initiated | Barclays | Underweight |
| Feb-04-20 | Resumed | Goldman | Neutral |
| Aug-13-18 | Initiated | Goldman | Neutral |
| Aug-13-18 | Initiated | Jefferies | Buy |
| Aug-13-18 | Initiated | William Blair | Outperform |
View All
Allakos Inc Stock (ALLK) Latest News
Can volume confirm reversal in Allakos Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
Is now a turning point for Allakos Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
How to recover losses in Allakos Inc. stockQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Can trapped investors hope for a rebound in Allakos Inc.Trade Exit Report & Safe Entry Zone Identification - Newser
Applying Wyckoff theory to Allakos Inc. stockForecast Cut & AI Enhanced Trade Execution Alerts - Newser
Applying sector rotation models to Allakos Inc.2025 Market Overview & Real-Time Volume Analysis Alerts - Newser
Is Allakos Inc. stock entering bullish territoryWeekly Trend Recap & Technical Pattern Based Signals - Newser
Best data tools to analyze Allakos Inc. stockEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Real time alert setup for Allakos Inc. performanceMarket Performance Report & Free Long-Term Investment Growth Plans - Newser
Does Allakos Inc. show high probability of reboundJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
Identifying reversal signals in Allakos Inc.July 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Risk adjusted return profile for Allakos Inc. analyzedJuly 2025 Recap & Technical Pattern Based Buy Signals - Newser
Is Allakos Inc. forming a bottoming baseEarnings Growth Summary & Verified Short-Term Plans - Newser
Custom strategy builders for tracking Allakos Inc.Chart Signals & Real-Time Chart Pattern Alerts - Newser
Developing predictive dashboards with Allakos Inc. dataWeekly Trade Recap & Verified Technical Trade Signals - Newser
Trend analysis for Allakos Inc. this weekMarket Rally & Expert-Curated Trade Recommendations - Newser
Key resistance and support levels for Allakos Inc.Weekly Risk Report & AI Based Buy and Sell Signals - Newser
How Resilient Is Allakos Inc. Stock During Economic DownturnsQuarterly Profit Summary & High Conviction Buy Zone Picks - Newser
What makes Allakos Inc. stock price move sharplyPortfolio Update Report & Reliable Price Breakout Alerts - Newser
How high can Allakos Inc. stock goMarket Sentiment Review & Growth Focused Investment Plans - Newser
What does recent volatility data suggest for Allakos Inc.2025 Market Sentiment & Community Driven Trade Alerts - Newser
Quantitative breakdown of Allakos Inc. recent moveJuly 2025 Update & Accurate Technical Buy Alerts - Newser
Allakos Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPortfolio Risk Summary & Daily Entry Point Alerts - Newser
Detecting price anomalies in Allakos Inc. with AI2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Should I add Allakos Inc. stock to my portfolioPortfolio Gains Report & Low Risk Profit Maximizing Plans - thegnnews.com
Is Allakos Inc. attractive for institutional investorsWeekly Investment Report & Long-Term Investment Growth Plans - thegnnews.com
Allakos Inc Stock (ALLK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):